BridgeBio Pharma ROA 2018-2024 | BBIO

Current and historical return on assets (ROA) values for BridgeBio Pharma (BBIO) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
BridgeBio Pharma ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2024-06-30 $-0.45B $0.79B -63.71%
2024-03-31 $-0.54B $0.85B -84.26%
2023-12-31 $-0.64B $0.55B -110.34%
2023-09-30 $-0.61B $0.66B -101.83%
2023-06-30 $-0.57B $0.50B -92.34%
2023-03-31 $-0.43B $0.63B -59.86%
2022-12-31 $-0.48B $0.62B -63.56%
2022-09-30 $-0.49B $0.73B -57.36%
2022-06-30 $-0.51B $0.86B -58.67%
2022-03-31 $-0.60B $0.81B -64.52%
2021-12-31 $-0.56B $1.01B -56.64%
2021-09-30 $-0.54B $0.78B -58.47%
2021-06-30 $-0.50B $1.08B -54.01%
2021-03-31 $-0.52B $1.09B -59.60%
2020-12-31 $-0.45B $0.70B -53.03%
2020-09-30 $-0.40B $0.79B -48.51%
2020-06-30 $-0.35B $0.91B -43.69%
2020-03-31 $-0.29B $0.99B -51.44%
2019-12-31 $-0.26B $0.63B -81.70%
2019-06-30 $-0.16B $0.00B inf%
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $4.791B $0.009B
BridgeBio Pharma Inc. discovers, develops and innovates drugs for genetic diseases. The Company's product platform consists of Mendelian, Oncology and Gene therapy. Its product pipeline includes BBP-265, BBP-831, BBP-631 and BBP-454 which are in clinical stage. BridgeBio Pharma Inc. is based in CA, United States.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $20.902B 7.10
Dr Reddy's Laboratories (RDY) India $12.399B 18.57
Bausch Health Cos (BHC) Canada $3.597B 2.61
Amphastar Pharmaceuticals (AMPH) United States $2.469B 13.82
Supernus Pharmaceuticals (SUPN) United States $1.872B 377.44
Taysha Gene Therapies (TSHA) United States $0.314B 51.00
Personalis (PSNL) United States $0.270B 0.00
Assembly Biosciences (ASMB) United States $0.107B 0.00
Acasti Pharma (GRCE) Canada $0.031B 0.00
Sol-Gel Technologies (SLGL) Israel $0.014B 0.00
Evoke Pharma (EVOK) United States $0.005B 0.00
Teligent (TLGT) United States $0.000B 0.00